二甲双胍、西格列汀与二甲双胍、达格列嗪与二甲双胍、利拉鲁肽对35-65岁UMF2型2型糖尿病患者疗效的比较研究

{"title":"二甲双胍、西格列汀与二甲双胍、达格列嗪与二甲双胍、利拉鲁肽对35-65岁UMF2型2型糖尿病患者疗效的比较研究","authors":"","doi":"10.58842/lzdq4436","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":498521,"journal":{"name":"Revista Ocronos","volume":"8 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Estudio comparativo de la eficacia terapéutica entre metformina, sitagliptina con metformina, dapagliflozina con metformina y liraglutida en pacientes con DM2 de 35-65 años de la UMF2\",\"authors\":\"\",\"doi\":\"10.58842/lzdq4436\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":498521,\"journal\":{\"name\":\"Revista Ocronos\",\"volume\":\"8 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Ocronos\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.58842/lzdq4436\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Ocronos","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.58842/lzdq4436","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}